Status:
RECRUITING
Coronary Artery Disease and Coronary Microvascular Disease in Cardiomyopathies Registry
Lead Sponsor:
University Hospital, Grenoble
Collaborating Sponsors:
Clinique Belledonne
Groupe Hospitalier Mutualiste de Grenoble
Conditions:
Hypertrophic
Ischemic
Eligibility:
All Genders
18-100 years
Brief Summary
Long-term prognostic value of macrovascular and microvascular coronary artery stenoses in each type of cardiomyopathy.
Detailed Description
Coronary artery imaging techniques have taken a central role in the assessment of cardiovascular (CV) diagnosis over the past two decades. Many patients with a cardiomyopathy are also found to have a ...
Eligibility Criteria
Inclusion
- Ischemic
- Dilated
- Hypertrophic
- Restrictive cardiomyopathy.
Exclusion
- Pregnant women
- Breastfeeding women
- Patients under legal protection
Key Trial Info
Start Date :
February 8 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 1 2028
Estimated Enrollment :
1600 Patients enrolled
Trial Details
Trial ID
NCT03479580
Start Date
February 8 2018
End Date
February 1 2028
Last Update
May 19 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Grenoble
La Tronche, France, 38700